German Consortium for Translational Cancer Research select CentraXX-Module Biobank (CBB)
The German Consortium for Translational Cancer Research (DKTK) will employ the CentraXX-module Biobank (CBB) for its oncological research at the partner site in Dresden. The system by the Kairos GmbH prevailed in a tenure to this end. The DKTK promotes interdisciplinary cancer research at the interface between fundamental research and clinic. It also carries out clinical studies about innovative therapeutic and diagnostic procedures.
The Kairos GmbH thus supplies a further „Oncological Center of Excellency” in Germany, underlining once more its own demand to continually further develop CentraXX to one of the leading research portals.
All CentraXX system solutions by Kairos GmbH are developed at the sites in Bochum and Berlin.